Factor Xa inhibitors: critical considerations for clinical development and testing
Crossref DOI link: https://doi.org/10.1007/s11239-021-02455-x
Published Online: 2021-05-15
Published Print: 2021-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Becker, Richard C. http://orcid.org/0000-0002-9878-7707
Text and Data Mining valid from 2021-05-15
Version of Record valid from 2021-05-15
Article History
Accepted: 13 April 2021
First Online: 15 May 2021
Free to read: This content has been made available to all.